These results and the current data in lavaged and HCl-treated young adult rabbits indicate that synthetic surfactants containing analogs of both SP-B and SP-C may be superior to single-peptide surfactants in the treatment of RDS and ALI/ARDS. The gene discussed is SFTPB; the disease is acute respiratory distress syndrome.